about
Association of Physical Fitness With the Risk of Atrial Fibrillation: A Systematic Review and Meta-AnalysisSex Differences in the Association Between Regular Physical Activity and Incident Atrial Fibrillation: A Meta-analysis of 13 Prospective StudiesThe HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysisThe effect of smoking on the risk of primary open-angle glaucoma: an updated meta-analysis of six observational studies.Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies.Genotype-based clinical manifestation and treatment of Chinese long QT syndrome patients with KCNQ1 mutations - R380S and W305L.A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study.Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.Relationship between epicardial adipose tissue volume and atrial fibrillation : A systematic review and meta-analysis.Relationship between retinal vascular occlusions and incident cerebrovascular diseases: A systematic review and meta-analysis.Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review.Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic ReviewMeta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: A systematic review and meta-analysis.Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population.Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.Variant rs2200733 and rs10033464 on chromosome 4q25 are associated with increased risk of atrial fibrillation after catheter ablation: Evidence from a meta-analysis.Generation of Mesenchymal-Like Stem Cells From Urine in Pediatric Patients.Re: Letter to the Editor in response to Kawada, 'The effect of smoking on the risk of primary open-angle glaucoma: an updated meta-analysis of six observational studies'.Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation.[Research update on urine-derived stem cells]O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic heartsEffect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysisDose-response relationship of cardiorespiratory fitness with incident atrial fibrillationNon-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world dataEfficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized TrialsNon-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysisReal-World Relationship Between Proton Pump Inhibitors and Cerebro-Cardiovascular Outcomes Independent of ClopidogrelThe obesity paradox for outcomes in atrial fibrillation: Evidence from an exposure-effect analysis of prospective studiesEfficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-AnalysisResting Heart Rate and the Risk of Atrial FibrillationBrugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis: A meta-analysisNon-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
P50
Q26749693-AB091AD7-79C4-4BB6-A404-A82B382C1E78Q26753179-3612F9CF-EF60-49B1-A516-3FFF2761DAAEQ26784497-112E4F52-577A-462A-ABD1-C14EAAB59967Q30248485-C93D4D80-8B78-4474-8EDB-7CD804EA7B68Q30250060-E7182651-8C72-4AB9-8677-20546E146EDBQ33166205-86DBF95E-AEAA-4232-B259-F78F3DE324E5Q33664288-F2A5593C-6477-48E4-8E85-D5E879979DF6Q35228412-A28D58E5-FC27-42C8-9EE5-60451122F5AAQ35867367-C1A09A11-D5DA-410E-8F62-2ED845091A3AQ36066147-4E40C6EF-7109-47DA-9930-E064A3FBBF97Q36097410-1F27846E-FEAF-4863-937A-7F2872C36F0AQ36103509-4A067F4C-7F62-4A66-A32D-E975B106EE11Q36129218-1B97CEC1-C473-4A12-BC9C-FDF1C619DEFCQ36191085-F661379D-2B90-45E9-9B7C-BB8ACE8EC9A2Q37605121-6D5EFFB4-905A-4962-9939-FAD12815B63AQ39188816-E41CF708-09C9-4B6F-BB9E-742501079258Q45330989-5387C4C3-4794-489C-83C4-5BBC11CDBD67Q47309904-A419AA87-80A8-49A9-B191-A22BB3916AEFQ50229968-167CFCF8-264D-4C2C-8A13-41EAA3B1C337Q54650247-8FD9A742-C373-4E7D-B1E6-66EF20B8E2E7Q64933467-B198213E-B8A5-4844-A8FB-373EB4488523Q85825260-8781410F-6E35-4F75-9C57-B99E047D1804Q88030793-72F597D0-6C6F-4F19-AC12-E6753B83C7C5Q90793154-27E35C94-1A44-4152-8FCB-FD60D99FBA82Q90951703-B5B2E394-BFF8-4993-B189-AFB9D707C91EQ90959548-F482A813-7B41-4ED2-B7F3-A7DF9F8CE05FQ91292050-6599C0FE-E929-4779-8430-F42F0F113BD9Q91623832-83B31FCE-4A03-4EF4-85B4-7F4439A7605CQ91901706-73FAAE13-64A4-499F-8339-BE66DBC3F375Q92066092-693EB234-B2B7-4C12-A96B-566442B93CA0Q92161891-D735FEEA-D72C-49C6-8113-1BA44BC0F4F9Q92783125-8DC5AA8B-CD21-43D4-9A5C-8D861AEDBF52Q92960965-63407765-EC18-4B19-BF57-4897624DBCF3Q93112361-ED3AD085-DD08-4F41-A402-9476ED69559C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Wengen Zhu
@en
Wengen Zhu
@nl
type
label
Wengen Zhu
@en
Wengen Zhu
@nl
prefLabel
Wengen Zhu
@en
Wengen Zhu
@nl
P31
P496
0000-0002-1280-0158